J Natl Compr Canc Netw. 2026 Jan;24(1):e260001. doi: 10.6004/jnccn.2026.0001.
ABSTRACT
The treatment landscape for multiple myeloma (MM) is evolving rapidly and includes several new options. The management must be tailored to the individual. The NCCN Guidelines for MM provide a framework to base decisions regarding diagnosis, workup, treatment, and follow-up of both newly diagnosed and previously treated relapsed/refractory MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to newly diagnosed MM (NDMM).
PMID:41671464 | DOI:10.6004/jnccn.2026.0001